These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2339131)

  • 21. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
    Honma Y; Hozumi M; Abe E; Konno K; Fukushima M; Hata S; Nishii Y; DeLuca HF; Suda T
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):201-4. PubMed ID: 6296868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.
    Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M
    Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).
    Zhou LX; Nemere I; Norman AW
    J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo.
    Lemire JM; Archer DC; Reddy GS
    Endocrinology; 1994 Dec; 135(6):2818-21. PubMed ID: 7988477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.
    Shabtay A; Sharabani H; Barvish Z; Kafka M; Amichay D; Levy J; Sharoni Y; Uskokovic MR; Studzinski GP; Danilenko M
    Oncology; 2008; 75(3-4):203-14. PubMed ID: 18852491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
    Farach-Carson MC; Sergeev I; Norman AW
    Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
    Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
    Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
    Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
    Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS; Farsoudi KH; Peterlik M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):105-10. PubMed ID: 8446178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines.
    de Vos S; Holden S; Heber D; Elstner E; Binderup L; Uskokovic M; Rude B; Chen DL; Le J; Cho SK; Koeffler HP
    Prostate; 1997 May; 31(2):77-83. PubMed ID: 9140119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
    Khoury R; Ridall AL; Norman AW; Farach-Carson MC
    Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma.
    Shternfeld IS; Lasudry JG; Chappell RJ; Darjatmoko SR; Albert DM
    Arch Ophthalmol; 1996 Nov; 114(11):1396-401. PubMed ID: 8906031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D analogs inhibit erythroid differentiation and induce monocytic differentiation of leukemic cells with the same relative potency.
    Kolla SS; Moore DC; Studzinski GP
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):214-7. PubMed ID: 2031057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.
    Clark JW; Posner MR; Marsella JM; Santos A; Uskokovic M; Eil C; Lasky SR
    J Cancer Res Clin Oncol; 1992; 118(3):190-4. PubMed ID: 1372318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis.
    Nakagawa K; Sowa Y; Kurobe M; Ozono K; Siu-Caldera ML; Reddy GS; Uskokovic MR; Okano T
    Steroids; 2001; 66(3-5):327-37. PubMed ID: 11179741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice.
    Abe J; Takita Y; Nakano T; Miyaura C; Suda T; Nishii Y
    Endocrinology; 1989 May; 124(5):2645-7. PubMed ID: 2539984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
    Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
    Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macrophages.
    Kizaki M; Ikeda Y; Simon KJ; Nanjo M; Koeffler HP
    Leukemia; 1993 Oct; 7(10):1525-30. PubMed ID: 7692190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.